Eli Lilly announced the launch of Trulicity ... RELATED: Trulicity Pen Approved for Type 2 Diabetes. Trulicity is available as 0.75 and 1.5mg single-use pens in 4-count cartons.

Trulicity, Eli Lilly’s best-selling drug, was also added to the FDA shortage list. Trulicity brought in $5.5 billion in 2022 up until September, according to the company’s latest quarterly financial ...

The Tempo Smart Button was cleared by the FDA in mid-September, Lilly said in this week’s announcement. When attached to the top of a Tempo insulin pen, it takes in and stores insulin dosing ...

Eli Lilly’s revenue rose from $22.3 billion in 2019 to $28.5 billion in 2022, driven by continued market share gains for some of its drugs, including Trulicity, Verzenio, Jardiance, and Covid-19 ...

Along the corridors of Indianapolis-based Eli Lilly, NBP may not have the brand swagger of Trulicity or Mounjaro, but as the drugmaker eyes a rich menu of growth opportunities, the sturdy acronym ...